• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

BG Medicine Inc

+ Add to Watchlist


0.219 EUR 0.002 0.92%

As of 05:00:34 ET on 12/18/2014.

Snapshot for BG Medicine Inc (RBM)

Open: 0.218 Day's Range: 0.218 - 0.219 Volume: 0
Previous Close: 0.217 52wk Range: 0.194 - 1.689 1-Yr Rtn: -68.40%

Stock Chart for RBM

No chart data available.
  • RBM:GR 0.218
  • 1D
  • 1M
  • 1Y
Interactive RBM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RBM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.2600
Est. PEG Ratio -
Market Cap (M EUR) 7.54
Shares Outstanding (M) 34.42
30 Day Average Volume 167
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RBM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RBM

BG Medicine, Inc. develops and markets diagnostic tests. The Company develops biomarkers that predict a patient's response to a drug therapy, determine the potential toxicity of therapeutic agents to patients, identify patients who have or are likely to develop a specific disease, predict a patient's prognosis once a disease has been diagnosed, and monitor a patient's disease progression.

Paul R SohmerPresident/CEOStephen P HallExec VP/CFO/Treasurer
Aram AdourianSenior VP/Chief Scientific Ofcr
More Company Profile & Key Executives for RBM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
  • RBM News

  • Industry News

No stories found
No stories found
Sponsored Links
sec ||= nil